351 related articles for article (PubMed ID: 25829048)
1. Effect of magnesium sulphate on sugammadex reversal time for neuromuscular blockade: a randomised controlled study.
Germano Filho PA; Cavalcanti IL; Barrucand L; Verçosa N
Anaesthesia; 2015 Aug; 70(8):956-61. PubMed ID: 25829048
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
3. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex.
Unterbuchner C; Ziegleder R; Graf B; Metterlein T
Acta Anaesthesiol Scand; 2015 Apr; 59(4):536-40. PubMed ID: 25582520
[TBL] [Abstract][Full Text] [Related]
4. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
5. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
[TBL] [Abstract][Full Text] [Related]
6. Magnesium sulphate effects on sugammadex reversal time - a reply.
Germano Filho PA
Anaesthesia; 2015 Dec; 70(12):1457-8. PubMed ID: 26558864
[No Abstract] [Full Text] [Related]
7. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
9. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
10. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
11. [Reversal of rocuronium-induced neuromuscular blockade with sugammadex in patients for cesarean delivery treated with magnesium sulfate].
Sakurai Y; Uchida M; Aiba J; Mimura F; Yamaguchi M; Kakumoto M
Masui; 2014 Mar; 63(3):315-9. PubMed ID: 24724442
[TBL] [Abstract][Full Text] [Related]
12. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
13. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
[TBL] [Abstract][Full Text] [Related]
14. Recurarization with magnesium sulfate administered after two minutes sugammadex reversal: A randomized, double-blind, controlled trial.
Germano-Filho PA; Cavalcanti IL; Micuci AJQR; Velarde LGC; de Boer HD; Verçosa N
J Clin Anesth; 2023 Oct; 89():111186. PubMed ID: 37393856
[TBL] [Abstract][Full Text] [Related]
15. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
16. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
[TBL] [Abstract][Full Text] [Related]
17. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
[TBL] [Abstract][Full Text] [Related]
18. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Findings vs. speculation.
Carron M; Ori C
Acta Anaesthesiol Scand; 2015 Aug; 59(7):946-7. PubMed ID: 25962433
[No Abstract] [Full Text] [Related]
19. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study.
Yamamoto S; Yamamoto Y; Kitajima O; Maeda T; Suzuki T
Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400
[TBL] [Abstract][Full Text] [Related]
20. Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients.
Loupec T; Frasca D; Rousseau N; Faure JP; Mimoz O; Debaene B
Anaesthesia; 2016 Mar; 71(3):265-72. PubMed ID: 26685122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]